Login / Signup

Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects.

Dimos D MitsikostasAndrzej DekundyAngelika HanschmannMichael AlthausAstrid ScheschonkaFernando PaganAbhishek Lenka
Published in: Current medical research and opinion (2021)
Subjects reported an effect onset from 5 days after injection lasting up to 20 weeks (maximum observation period). Data indicate that incobotulinumtoxinA re-treatment of blepharospasm may not be required at fixed 12-week intervals and provide evidence for a patient-tailored approach.
Keyphrases
  • botulinum toxin
  • randomized controlled trial
  • clinical trial
  • machine learning
  • smoking cessation
  • ultrasound guided
  • replacement therapy